| Antigen | 18-aa peptide from Human CUGBP2 (gene accession # O95319, refs 1); Designation (CUGBP21-P, control peptide) |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | The CUGBP21-P control peptide is 100% conserved in rat, mouse and human CUGBP2. No significant conservation of CUGBP21-P is observed with other CUGBP1 or other proteins. Since the epitope of CUGBP21-P is located at the C-terminus, the antibodies are expected to react with all isoforms 1-5. Antibody cross-reactivity in various species or isoforms has not been studied. Control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. It should be used for ELISA or antibody blocking experiments (use 5-10 ug control peptide per 1 ug of aff pure IgG or 1 ul antiserum) to confirm antibody specificity |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |